Citadel Advisors
CANO

Citadel Advisors’s Cano Health, Inc. CANO Stock Holding History

Citadel Advisors’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-498
Closed -$12.6K – 15686
2023
Q3 		$12.6K Sell
498
-87
-15% -$7.15K ﹤0.01% 12957
2023
Q2 		$81.3K Buy
585
+269
+85% +$34.5K ﹤0.01% 11230
2023
Q1 		$28.8K Sell
316
-58
-16% -$7.87K ﹤0.01% 12772
2022
Q4 		$51.2K Sell
374
-1,116
-75% -$378K ﹤0.01% 12106
2022
Q3 		$1.29M Buy
1,490
+972
+188% +$609K ﹤0.01% 6448
2022
Q2 		$227K Sell
518
-1,117
-68% -$582K ﹤0.01% 10437
2022
Q1 		$1.04M Buy
1,635
+417
+34% +$263K ﹤0.01% 7604
2021
Q4 		$1.08M Sell
1,218
-909
-43% -$955K ﹤0.01% 7747
2021
Q3 		$2.7M Buy
2,127
+943
+80% +$1.14M ﹤0.01% 5616
2021
Q2 		$1.43M Buy
+1,184
New +$1.6M ﹤0.01% 7424

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors's CANO Position: Q4 2023 in Review

Citadel Advisors sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 3,682 shares — an estimated $93.4K sold.

Citadel Advisors first reported a position in CANO in Q4 2020 and held it in 11 quarters. The position peaked at $71.3M in Q2 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Citadel Advisors reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 3,682 Cano Health, Inc. shares in Q4 2023, an estimated $93.4K.
  • Citadel Advisors first reported a position in Cano Health, Inc. in Q4 2020 and held it in 11 quarters.
  • Citadel Advisors's Cano Health, Inc. position peaked at $71.3M in Q2 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.